CIMIP1 and lung carcinoma: C20orf85 (also known as low in lung cancer 1) was initially described to be downregulated in lung cancer samples compared to normal tissue [85]; subsequently, the same authors showed that C20orf85 localizes to the ciliated cells of the upper airways, and, when overexpressed in cell models of lung cancer, did not affect proliferation or migration [86].